论文部分内容阅读
目的了解麻醉药品的执行及应用情况和趋势,为指导临床合理用药提供参考。方法收集2005—2009年麻醉药品的应用数据,对其用量、处方数量及癌症患者用药情况进行分析。结果麻醉药品消费金额逐年增加;盐酸瑞芬太尼注射液、盐酸吗啡缓释片、羟考酮控释片和枸橼酸舒芬太尼注射液消费金额位居前4位;盐酸布桂嗪片的用量较大,增长迅速;盐酸哌替啶制剂用量虽呈下降趋势,但其用量还很大;盐酸吗啡缓释片和羟考酮控释片癌症患者处方量逐年上升,且所占比例很大。结论麻醉药品的使用总体趋向合理,但也存在一些不足,需进一步改善用药结构,以期临床使用上更加合理化、人性化。
Objective To understand the implementation and application of narcotic drugs and trends in order to guide clinical rational use of drugs provide a reference. Methods The application data of narcotic drugs from 2005 to 2009 were collected, and their dosage, the number of prescriptions and the medication of cancer patients were analyzed. Results The consumption amount of narcotic drugs increased year by year. The consumption amount of remifentanil hydrochloride injection, morphine hydrochloride sustained-release tablets, oxycodone controlled-release tablets and sufentanil citrate topped the top 4 positions. Budenazine hydrochloride The dosage of pethidine hydrochloride showed a decreasing trend, but its dosage was still high. The prescriptions of morphine hydrochloride sustained release tablets and oxycodone controlled release tablets increased year by year, and the proportion of them Great. Conclusion The overall use of narcotic drugs tends to be reasonable, but there are also some shortcomings. It is necessary to further improve the drug use structure so as to make the clinical use more rational and humane.